ArticleJournal of nanobiotechnology2026
Engineered lipid hybrid nanoparticles for targeted delivery of SH2 superbinder and breast cancer therapy.
Yuhe Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it